Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease
- PMID: 21122568
- DOI: 10.1016/j.crohns.2010.05.001
Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease
Abstract
We present the case of a 28 year old lady with refractory Crohn's Disease treated with infliximab throughout her pregnancy. Her baby was born healthy and received a Bacillus Calmette-Guérin (BCG) vaccine aged 3 months. Soon after this the infant became unwell and died aged 4.5 months. At post-mortem the cause of death was attributed to an unusual complication of the BCG vaccine, known as disseminated BCG. BCG vaccination is contraindicated in individuals who are receiving immunosuppressive drugs. We recommend physicians should exercise caution before such vaccines are used in infants born to mothers taking anti-TNF therapies or other potentially immunosuppressive IgG1 antibodies.
Copyright © 2010 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
Comment in
-
Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab.J Am Acad Dermatol. 2011 Oct;65(4):870. doi: 10.1016/j.jaad.2011.04.030. J Am Acad Dermatol. 2011. PMID: 21920245 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
